PCV48 Cost-Effectiveness of Dabigatran Etexilate Versus Acetylsalicilic Acid for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation Under the Private and Public Health Care System in Brazil
Jun 1, 2012, 00:00
10.1016/j.jval.2012.03.651
https://www.valueinhealthjournal.com/article/S1098-3015(12)00716-4/fulltext
Title :
PCV48 Cost-Effectiveness of Dabigatran Etexilate Versus Acetylsalicilic Acid for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation Under the Private and Public Health Care System in Brazil
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)00716-4&doi=10.1016/j.jval.2012.03.651
First page :
A120
Section Title :
Cardiovascular Disorders
Open access? :
No
Section Order :
124